Top

Published in:

01-04-2011 | Case Report

Kitten-transmitted Bordetella bronchiseptica infection in a patient receiving temozolomide for glioblastoma

Authors: Gil Redelman-Sidi, Christian Grommes, Genovefa Papanicolaou

Published in: Journal of Neuro-Oncology | Issue 2/2011

Abstract

Bordetella bronchiseptica is a gram negative coccobacillus that can be transmitted from domestic animals and cause severe infections in immunocompromised patients. A 56-year-old man with a left parietal glioblastoma was treated with resection, radiation and concomitant and adjuvant temozolomide chemotherapy. He received bevacizumab for progression, and dose dense metronomic temozolomide was added for additional progression. He developed chronic cough and was diagnosed with B. bronchiseptica infection. This is the first reported case of B. bronchiseptica infection in a patient receiving temozolomide. The infection was likely acquired from an infected kitten. Patients receiving temozolomide should be counseled on the risks of acquiring zoonotic infections, including B. bronchiseptica, from their pets.

Woolfrey BF, Moody JA (1991) Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev 4:243–255PubMed

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987–996PubMedCrossRef

Su YB, Sohn S, Krown SE, Livingston PO, Wolchok JD, Quinn C, Williams L, Foster T, Sepkowitz KA, Chapman PB (2004) Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. J Clin Oncol 22:610–616PubMedCrossRef

Lampe AS, van der Reijden TJ (1984) Evaluation of commercial test systems for the identification of nonfermenters. Eur J Clin Microbiol 3:301–305PubMedCrossRef

Yu SK, Chalmers AJ (2007) Patients receiving standard-dose temozolomide therapy are at risk of Pneumocystis carinii pneumonia. Clin Oncol (R Coll Radiol) 19:631–632

Aregawi D, Lopez D, Wick M, Scheld WM, Schiff D (2009) Disseminated strongyloidiasis complicating glioblastoma therapy: a case report. J Neurooncol 94:439–443PubMedCrossRef

Choi JD, Powers CJ, Vredenburgh JJ, Friedman AH, Sampson JH (2008) Cryptococcal meningitis in patients with glioma: a report of two cases. J Neurooncol 89:51–53PubMedCrossRef

De Jesus A, Grossman SA, Paun O (2009) Cytomegalovirus associated colonic pseudotumor: a consequence of iatrogenic immunosuppression in a patient with primary brain tumor receiving radiation and temozolomide. J Neurooncol 94:445–448PubMedCrossRef

Yaman E, Coskun U, Ozturk B, Buyukberber S, Kaya AO, Coskun O, Buyukberber N, Yildiz R, Benekli M (2009) Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma. J Clin Neurosci 16:591–592PubMedCrossRef

10.

de Paiva TF Jr, de Barros e Silva MJ, Rinck JA Jr, Fanelli MF, Gimenes DL (2009) Tuberculosis in a patient on temozolomide: a case report. J Neurooncol 92:33–35PubMedCrossRef

11.

Grewal J, Dellinger CA, Yung WK (2007) Fatal reactivation of hepatitis B with temozolomide. N Engl J Med 356:1591–1592PubMedCrossRef

12.

Georgescu G, Isola IM, Youssef S, Adachi J, Rolston K (2008) Disseminated salmonellosis in a patient treated with temozolomide. J Infect 57:414–415PubMedCrossRef

13.

Hughes MA, Parisi M, Grossman S, Kleinberg L (2005) Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection. Int J Radiat Oncol Biol Phys 62:1423–1426PubMedCrossRef

14.

Goodnow RA (1980) Biology of Bordetella bronchiseptica. Microbiol Rev 44:722–738PubMed

15.

Jørgensen K, Aalbæk B, Hilberg C, Vintov J, Laurits Larsen J, Aalbæk B (2000) Online photo atlas. The Royal Veterinary and Agricultural University (KVL), Copenhagen. http://www.microbiologyatlas.kvl.dk/bakteriologi/english/showmorf.asp?articleid=52

16.

Dworkin MS, Sullivan PS, Buskin SE, Harrington RD, Olliffe J, MacArthur RD, Lopez CE (1999) Bordetella bronchiseptica infection in human immunodeficiency virus-infected patients. Clin Infect Dis 28:1095–1099PubMedCrossRef

17.

Choy KW, Wulffraat NM, Wolfs TF, Geelen SP, Kraaijeveld CA, Fleer A (1999) Bordetella bronchiseptica respiratory infection in a child after bone marrow transplantation. Pediatr Infect Dis J 18:481–483PubMedCrossRef

18.

Ner Z, Ross LA, Horn MV, Keens TG, MacLaughlin EF, Starnes VA, Woo MS (2003) Bordetella bronchiseptica infection in pediatric lung transplant recipients. Pediatr Transplant 7:413–417PubMedCrossRef

19.

Bauwens JE, Spach DH, Schacker TW, Mustafa MM, Bowden RA (1992) Bordetella bronchiseptica pneumonia and bacteremia following bone marrow transplantation. J Clin Microbiol 30:2474–2475PubMed

20.

Byrd LH, Anama L, Gutkin M, Chmel H (1981) Bordetella bronchiseptica peritonitis associated with continuous ambulatory peritoneal dialysis. J Clin Microbiol 14:232–233PubMed

21.

Lo Re V 3rd, Brennan PJ, Wadlin J, Weaver R, Nachamkin I (2001) Infected branchial cleft cyst due to Bordetella bronchiseptica in an immunocompetent patient. J Clin Microbiol 39:4210–4212PubMedCrossRef

22.

Gueirard P, Weber C, Le Coustumier A, Guiso N (1995) Human Bordetella bronchiseptica infection related to contact with infected animals: persistence of bacteria in host. J Clin Microbiol 33:2002–2006PubMed

23.

Belen O, Campos JM, Cogen PH, Jantausch BA (2003) Postsurgical meningitis caused by Bordetella bronchiseptica. Pediatr Infect Dis J 22:380–381PubMed

24.

Barrio VR, Darmstadt GL (2000) Rash and opportunistic pneumonia in a malnourished infant adopted from China. Clin Infect Dis 30:408–409PubMedCrossRef

25.

Berkowitz DM, Bechara RI, Wolfenden LL (2007) An unusual cause of cough and dyspnea in an immunocompromised patient. Chest 131:1599–1602PubMedCrossRef

26.

de la Fuente J, Albo C, Rodriguez A, Sopena B, Martinez C (1994) Bordetella bronchiseptica pneumonia in a patient with AIDS. Thorax 49:719–720PubMedCrossRef

27.

Viejo G, de la Iglesia P, Otero L, Blanco MI, Gomez B, De Miguel D, Del Valle A, De la Fuente B (2002) Bordetella bronchiseptica pleural infection in a patient with AIDS. Scand J Infect Dis 34:628–629PubMedCrossRef

28.

Galeziok M, Roberts I, Passalacqua JA (2009) Bordetella bronchiseptica pneumonia in a man with acquired immunodeficiency syndrome: a case report. J Med Case Reports 3:76PubMedCrossRef

29.

Garcia San Miguel L, Quereda C, Martinez M, Martin-Davila P, Cobo J, Guerrero A (1998) Bordetella bronchiseptica cavitary pneumonia in a patient with AIDS. Eur J Clin Microbiol Infect Dis 17:675–676PubMedCrossRef

30.

Gisel JJ, Brumble LM, Johnson MM (2010) Bordetella bronchiseptica pneumonia in a kidney-pancreas transplant patient after exposure to recently vaccinated dogs. Transpl Infect Dis 12(1):73–76PubMedCrossRef

31.

Goldberg JD, Kamboj M, Ford R, Kiehn TE, Gilhuley K, Perales MA (2009) ‘Kennel cough’ in a patient following allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant 44:381–382PubMedCrossRef

32.

Gomez L, Grazziutti M, Sumoza D, Beran M, Rolston K (1998) Bacterial pneumonia due to Bordetella bronchiseptica in a patient with acute leukemia. Clin Infect Dis 26:1002–1003PubMedCrossRef

33.

Huebner ES, Christman B, Dummer S, Tang YW, Goodman S (2006) Hospital-acquired Bordetella bronchiseptica infection following hematopoietic stem cell transplantation. J Clin Microbiol 44:2581–2583PubMedCrossRef

34.

Jimenez-Lucho V, Shulman M, Johnson J (1994) Bordetella bronchiseptica in an AIDS patient cross-reacts with Legionella antisera. J Clin Microbiol 32:3095–3096PubMed

35.

Libanore M, Rossi MR, Pantaleoni M, Bicocchi R, Carradori S, Sighinolfi L, Ghinelli F (1995) Bordetella bronchiseptica pneumonia in an AIDS patient: a new opportunistic infection. Infection 23:312–313PubMedCrossRef

36.

Lorenzo-Pajuelo B, Villanueva JL, Rodriguez-Cuesta J, Vergara-Irigaray N, Bernabeu-Wittel M, Garcia-Curiel A, Martinez de Tejada G (2002) Cavitary pneumonia in an AIDS patient caused by an unusual Bordetella bronchiseptica variant producing reduced amounts of pertactin and other major antigens. J Clin Microbiol 40:3146–3154PubMedCrossRef

37.

Petrocheilou-Paschou V, Georgilis K, Kostis E, Prifti H, Zakopoulos N, Stamatelopoulos S (2000) Bronchitis caused by Bordetella bronchiseptica in an elderly woman. Clin Microbiol Infect 6:147–148PubMedCrossRef

38.

Rath BA, Register KB, Wall J, Sokol DM, Van Dyke RB (2008) Persistent Bordetella bronchiseptica pneumonia in an immunocompetent infant and genetic comparison of clinical isolates with kennel cough vaccine strains. Clin Infect Dis 46:905–908PubMedCrossRef

39.

Shimoni Z, Niven M, Mosenkis M, Greif J (2000) Fatal pneumonia due to Bordetella bronchiseptica. Isr Med Assoc J 2:402–403PubMed

40.

Stefanelli P, Mastrantonio P, Hausman SZ, Giuliano M, Burns DL (1997) Molecular characterization of two Bordetella bronchiseptica strains isolated from children with coughs. J Clin Microbiol 35:1550–1555PubMed

41.

Stevens-Krebbers AH, Schouten MA, Janssen J, Horrevorts AM (1999) Nosocomial transmission of Bordetella bronchiseptica. J Hosp Infect 43:323–324PubMedCrossRef

42.

Tamion F, Girault C, Chevron V, Pestel M, Bonmarchand G (1996) Bordetella bronchoseptica pneumonia with shock in an immunocompetent patient. Scand J Infect Dis 28:197–198PubMedCrossRef

43.

Wallet F, Perez T, Armand S, Wallaert B, Courcol RJ (2002) Pneumonia due to Bordetella bronchiseptica in a cystic fibrosis patient: 16S rRNA sequencing for diagnosis confirmation. J Clin Microbiol 40:2300–2301PubMedCrossRef

44.

Wernli D, Emonet S, Schrenzel J, Harbarth S (2010) Evaluation of 8 cases of confirmed Bordetella bronchiseptica infection and colonization over a 15-year period. Clin Microbiol Infect

45.

Won KB, Ha GY, Kim JS, Kang HJ, Tak WT, Lee JH (2009) Relapsing peritonitis caused by Bordetella bronchiseptica in continuous ambulatory peritoneal dialysis patient: a case report. J Korean Med Sci 24(Suppl):S215–S218PubMedCrossRef

46.

Word BM (2006) Cough and apnea in a young infant. Semin Pediatr Infect Dis 17(54):105–106CrossRef

47.

Katzenstein DA, Ciofalo L, Jordan MC (1984) Bordetella bronchiseptica bacteremia. West J Med 140:96–98PubMed

48.

Heininger U, Schmidt-Schlapfer G, Cherry JD, Stehr K (2000) Clinical validation of a polymerase chain reaction assay for the diagnosis of pertussis by comparison with serology, culture, and symptoms during a large pertussis vaccine efficacy trial. Pediatrics 105:E31PubMedCrossRef

49.

Register KB, Nicholson TL (2007) Misidentification of Bordetella bronchiseptica as Bordetella pertussis using a newly described real-time PCR targeting the pertactin gene. J Med Microbiol 56:1608–1610PubMedCrossRef

50.

Richards JR, Elston TH, Ford RB, Gaskell RM, Hartmann K, Hurley KF, Lappin MR, Levy JK, Rodan I, Scherk M, Schultz RD, Sparkes AH (2006) The 2006 American Association of Feline Practitioners Feline Vaccine Advisory Panel report. J Am Vet Med Assoc 229:1405–1441PubMedCrossRef

51.

Paul MA, Carmichael LE, Childers H, Cotter S, Davidson A, Ford R, Hurley KF, Roth JA, Schultz RD, Thacker E, Welborn L (2006) 2006 AAHA canine vaccine guidelines. J Am Anim Hosp Assoc 42:80–89PubMed

52.

Segal BH, Freifeld AG, Baden LR, Brown AE, Casper C, Dubberke E, Gelfand M, Greene JN, Ison MG, Ito JI, Karp JE, Kaul DR, King E, Mackler E, Marcucci G, Montoya JG, Engemann AM, Rolston K, The AS (2008) Prevention and treatment of cancer-related infections. J Natl Compr Canc Netw 6:122–174PubMed

Title: Kitten-transmitted Bordetella bronchiseptica infection in a patient receiving temozolomide for glioblastoma
Authors: Gil Redelman-Sidi
Christian Grommes
Genovefa Papanicolaou
Publication date: 01-04-2011
Publisher: Springer US
Published in: Journal of Neuro-Oncology / Issue 2/2011
Print ISSN: 0167-594X
Electronic ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-010-0322-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Kitten-transmitted Bordetella bronchiseptica infection in a patient receiving temozolomide for glioblastoma

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2011

MMP-9 expression in meningiomas: a prognostic marker for recurrence risk?

hHSS1: a novel secreted factor and suppressor of glioma growth located at chromosome 19q13.33

Erratum to: Intensity modulated radiation therapy or stereotactic fractionated radiotherapy for infratentorial ependymoma in children: a multicentric study

Intensity modulated radiation therapy or stereotactic fractionated radiotherapy for infratentorial ependymoma in children: a multicentric study

DTI and PWI analysis of peri-enhancing tumoral brain tissue in patients treated for glioblastoma

Growth curve analysis of asymptomatic and symptomatic meningiomas